We found that there is a strong correlation between cytolytic activity and the expression of PD-Ls (both PD-L1 and PD-L2) in HCC patients (Figure 6C), suggesting that immune response in cytolytic-high HCC samples can elicit tumor mechanisms of immune suppression regulated by PD-Ls. Here, PDCD1LG2 is linked to neoplasm.